bioRxivBiophysics
The Structural Basis of Indisulam-Mediated Recruitment of RBM39 to the DCAF15-DDB1-DDA1 E3 Ligase Complex
D. E. Bussiere, L. Xie, W. Shu, H. Srinivas, W. Shu, A. Burke, C. Be, J. Zhao, A. Godbole, D. King, R. G. Karki, V. Hornak, F. Xu, J. Cobb, N. Carte, A. O. Frank, A. Frommlet, P. Graff, M. Knapp, A. Fazal, B. Okram, S. Jiang, P.-Y. Michellys, R. Beckwith, H. Voshol, , J. Paulk
Abstract
The anti-cancer agent Indisulam inhibits cell proliferation by causing degradation of RBM39, an essential mRNA splicing factor. Indisulam promotes an interaction between RBM39 and the DCAF15 E3 ligase substrate receptor leading to RBM39 ubiquitination and proteasome-mediated degradation. To delineate the precise mechanism by which Indisulam mediates DCAF15-RBM39 interaction, we solved the DCAF15-DDB1-DDA1-Indisulam-RBM39(RRM2) complex structure to 2.3 [A]. DCAF15 has a novel topology which embraces the RBM39(RRM2) domain largely via nonpolar interactions, and Indisulam binds between DCAF15 and RBM39(RRM2) and coordinates additional interactions between the two proteins. Studies with RBM39 point mutants and Indisulam analogs validated the structural model and defined the RBM39 alpha-helical degron motif. The degron is found only in RBM23 and RBM39 and only these proteins were detectably downregulated in Indisulam-treated HCT116 cells. This work further explains how Indisulam induces RBM39 degradation and defines the challenge of harnessing DCAF15 to degrade novel targets.
- organism: human
- assay: structural biology
- research focus: protein structure prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
T. Faust, H. Yoon, … E. S. Fischer·bioRxiv·Aug 16, 2019
- Structural basis of recruitment of RBM39 to DCAF15 by a sulfonamide molecular glue E7820
X. Du, O. A. Volkov, … E. Wallace·bioRxiv·Sep 5, 2019
- Genetic and compound screens uncover factors modulating cancer cell response to indisulam
Z. Pogacar, K. Groot, … R. Leite de Oliveira·bioRxiv·Dec 20, 2021
- The cancer-associated RBM39 bridges the pre-mRNA, U1 and U2 snRNPs to regulate alternative splicing
Sébastien Campagne, Daniel Jutzi, … Frédéric H.‐T. Allain·bioRxiv·Aug 30, 2022
- The KRAS G12C Inhibitor Divarasib Stabilizes RBM39 and Antagonizes Aryl-Sulfonamide Degraders
Ssu-Yu Chen, You Zou, … Jen‐Tsan Chi·bioRxiv·Aug 20, 2026
- Arylsulfonamide mediated RBM39 degradation causes aberrant splicing of mitotic kinesins
Seemon Coomar, Alexander V. Penson, … Dennis G. Gillingham·bioRxiv·Feb 1, 2021